Found: 71
Select item for more details and to access through your institution.
CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ς-chain expression in T cells.
- Published in:
- Rheumatology, 2017, v. 56, n. 3, p. 467, doi. 10.1093/rheumatology/kew405
- By:
- Publication type:
- Article
Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients.
- Published in:
- Rheumatology, 2016, v. 55, n. 9, p. 1673, doi. 10.1093/rheumatology/kew213
- By:
- Publication type:
- Article
Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2016, v. 55, n. 3, p. 441, doi. 10.1093/rheumatology/kev344
- By:
- Publication type:
- Article
Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2010, v. 49, n. 12, p. 2381
- By:
- Publication type:
- Article
Parvovirus B19 and Onset of Juvenile Dermatomyositis.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Myositis: Immunologic contributions to understanding cause, pathogenesis, and therapy.
- Published in:
- Annals of Internal Medicine, 1995, v. 122, n. 9, p. 715, doi. 10.7326/0003-4819-122-9-199505010-00010
- By:
- Publication type:
- Article
Development of a computed tomography calcium scoring technique for assessing calcinosis distribution, pattern and burden in dermatomyositis.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 58, doi. 10.1093/rheumatology/kead256
- By:
- Publication type:
- Article
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3757, doi. 10.1093/rheumatology/kead203
- By:
- Publication type:
- Article
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3672, doi. 10.1093/rheumatology/kead110
- By:
- Publication type:
- Article
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. 3161, doi. 10.1093/rheumatology/kead033
- By:
- Publication type:
- Article
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2864, doi. 10.1093/rheumatology/keac687
- By:
- Publication type:
- Article
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
- Published in:
- Rheumatology, 2023, v. 62, p. SI226, doi. 10.1093/rheumatology/keac428
- By:
- Publication type:
- Article
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2022, v. 61, n. 7, p. 2969, doi. 10.1093/rheumatology/keab846
- By:
- Publication type:
- Article
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
- Published in:
- Rheumatology, 2022, v. 61, p. SI143, doi. 10.1093/rheumatology/keac249
- By:
- Publication type:
- Article
Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM).
- Published in:
- Rheumatology, 2022, v. 61, p. SI48, doi. 10.1093/rheumatology/keab833
- By:
- Publication type:
- Article
Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2134, doi. 10.1093/rheumatology/keaa371
- By:
- Publication type:
- Article
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1839, doi. 10.1093/rheumatology/keaa429
- By:
- Publication type:
- Article
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 829, doi. 10.1093/rheumatology/keaa436
- By:
- Publication type:
- Article
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
- Published in:
- Rheumatology, 2018, v. 57, n. 11, p. 1956, doi. 10.1093/rheumatology/key190
- By:
- Publication type:
- Article
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria--methodological aspects.
- Published in:
- Rheumatology, 2017, v. 56, n. 11, p. 1884, doi. 10.1093/rheumatology/kex226
- By:
- Publication type:
- Article
Environmental factors associated with disease flare in juvenile and adult dermatomyositis.
- Published in:
- Rheumatology, 2017, v. 56, n. 8, p. 1342, doi. 10.1093/rheumatology/kex162
- By:
- Publication type:
- Article
Deciphering the Clinical Presentations, Pathogenesis, and Treatment of the Idiopathic Inflammatory Myopathies.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology.
- Published in:
- Pediatric Rheumatology, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12969-018-0261-x
- By:
- Publication type:
- Article
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.
- Published in:
- Pediatric Rheumatology, 2017, v. 14, p. 1, doi. 10.1186/s12969-016-0134-0
- By:
- Publication type:
- Article
Parents' perception of self-advocacy of children with myositis: an anonymous online survey.
- Published in:
- Pediatric Rheumatology, 2011, v. 9, n. 1, p. 10, doi. 10.1186/1546-0096-9-10
- By:
- Publication type:
- Article
47XXY and 47XXX in Scleroderma and Myositis.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 6, p. 528, doi. 10.1002/acr2.11413
- By:
- Publication type:
- Article
Myositis‐Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 6, p. 963, doi. 10.1002/art.42813
- By:
- Publication type:
- Article
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ Juvenile‐Onset Dermatomyositis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 631, doi. 10.1002/art.42768
- By:
- Publication type:
- Article
Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 11, p. 2014, doi. 10.1002/art.42615
- By:
- Publication type:
- Article
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1856, doi. 10.1002/art.42534
- By:
- Publication type:
- Article
Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1668, doi. 10.1002/art.42512
- By:
- Publication type:
- Article
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 7, p. 1229, doi. 10.1002/art.42450
- By:
- Publication type:
- Article
Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome‐Wide Imputation.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 6, p. 1021, doi. 10.1002/art.42434
- By:
- Publication type:
- Article
Conflicting reports of anti–cytosolic 5′‐nucleotidase 1A autoantibodies in juvenile dermatomyositis: comment on the article by Rietveld et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 2, p. 358, doi. 10.1002/art.41931
- By:
- Publication type:
- Article
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 11, p. 1945, doi. 10.1002/art.41390
- By:
- Publication type:
- Article
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 911, doi. 10.1002/art.40060
- By:
- Publication type:
- Article
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 898, doi. 10.1002/art.40064
- By:
- Publication type:
- Article
Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 3, p. 761, doi. 10.1002/art.39466
- By:
- Publication type:
- Article
A25: The Association of Immunogenetic and Environmental Factors with Disease Course in Patients with Juvenile Idiopathic Inflammatory Myopathies.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S39, doi. 10.1002/art.38441
- By:
- Publication type:
- Article
A47: Progress Report on the Development of New Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S70, doi. 10.1002/art.38463
- By:
- Publication type:
- Article
A58: Demographics, Clinical Features and Therapies of Patients with Juvenile Dermatomyositis Participating in a National Myositis Patient Registry.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S86, doi. 10.1002/art.38474
- By:
- Publication type:
- Article
Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 3, p. 740, doi. 10.1002/art.38270
- By:
- Publication type:
- Article
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
- Published in:
- Pediatric Rheumatology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12969-022-00684-9
- By:
- Publication type:
- Article
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Postlicensure Safety Surveillance for Varicella Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2000, v. 284, n. 10, p. 1271, doi. 10.1001/jama.284.10.1271
- By:
- Publication type:
- Article
Post-Zygotic and Inter-Individual Structural Genetic Variation in a Presumptive Enhancer Element of the Locus between the <i>IL10Rβ</i> and <i>IFNAR1</i> Genes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0067752
- By:
- Publication type:
- Article
The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02160-9
- By:
- Publication type:
- Article